Lung Cancer Risk Prediction Models for Asian Ever-Smokers

Abstract

Introduction: Although lung cancer prediction models are widely used to support risk -based screening, their performance outside Western populations remains uncertain. This study aims to evaluate the performance of 11 existing risk prediction models in multiple Asian populations and to refit prediction models for Asians. Methods: In a pooled analysis of 186,458 Asian eversmokers from 19 prospective cohorts, we assessed calibration (expected -to -observed ratio) and discrimination (area under the receiver operating characteristic curve [AUC]) for each model. In addition, we developed the "Shanghai models" to better refine risk models for Asians on the basis of two well -characterized population -based prospective cohorts and externally validated them in other Asian cohorts. Results: Among the 11 models, the Lung Cancer Death Risk Assessment Tool yielded the highest AUC (AUC [95% confidence interval (CI)] = 0.71 [0.67-0.74] for lung cancer death and 0.69 [0.67-0.72] for lung cancer incidence) and the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Model had good calibration overall (expected -to -observed ratio [95% CI] = 1.06 [0.90-1.25]). Nevertheless, these models substantially underestimated lung cancer risk among Asians who reported less than 10 smoking pack -years or stopped smoking more than or equal to 20 years ago. The Shanghai models were found to have marginal improvement overall in discrimination (AUC [95% CI] = 0.72 [0.69-0.74] for lung cancer death and 0.70 [0.67- 0.72] for lung cancer incidence) but consistently outperformed the selected Western models among lowintensity smokers and long-term quitters. Conclusions: The Shanghai models had comparable performance overall to the best existing models, but they improved much in predicting the lung cancer risk of lowintensity smokers and long-term quitters in Asia. (c) 2023 Published by Elsevier Inc. on behalf of International Association for the Study of Lung Cancer.